Kimberly Gentile, SVP, Clinical Operations at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 400 shares at $70.20 ($28K) on 2020-06-17, disclosed to the SEC on 2020-06-18.
Scheduled sale ($28k) by SVP, Clinical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| BHVN | SELL | 2020-06-10 | $42K | — | Filing → |
| BHVN | SELL | 2019-11-22 | $2.7M | — | Filing → |
| BHVN | SELL | 2018-06-19 | $1.0M | — | Filing → |